⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HUMA News
Humacyte, Inc. Common Stock
Humacyte Announces Publication of New Data Comparing Symvess™ to Autologous Vein in Extremity Arterial Trauma
globenewswire.com
HUMA
D. Boral Capital Acted as Exclusive Placement Agent to Humacyte (Nasdaq: HUMA) in Connection with its $60,000,000 Registered Direct Offering
accessnewswire.com
HUMA
HUMA
Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering
globenewswire.com
HUMA
Humacyte Announces Publication of Long-Term Results for Ukrainian Patients Treated in Real-World Combat Setting with Symvess™
globenewswire.com
HUMA
Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus
globenewswire.com
HUMA